Chemical stem cell signature predicts treatment response for acute myeloid leukemia
Tuesday, February 4, 2014 - 06:01
in Health & Medicine
Researchers have found a chemical “signature” in blood-forming stem cells that predicts whether patients with acute myeloid leukemia (AML) will respond to chemotherapy.